Home › Type 2 Diabetes › North Carolina › Greenville
Type 2 Diabetes clinical trials in Greenville, NC
5 studies for Type 2 Diabetes are looking for participants at sites in and around Greenville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Physicians East, PA, Greenville
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecruitingPhase 3
- AURORA-2 Clinical Site, Greenville
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
RecruitingPhase 2
- Eastern Nephrology Associates - Greenville West, Greenville
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
RecruitingPhase 2
- Physicians East, Greenville
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
RecruitingPhase 3
- Research Site, Kinston · 27 mi away
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL25 studies
- Boston, MA20 studies
- Chicago, IL19 studies
- Dallas, TX19 studies
- Miami, FL19 studies
- Columbus, OH18 studies
- Las Vegas, NV18 studies
- San Diego, CA17 studies
- Atlanta, GA17 studies
- Los Angeles, CA16 studies
Other studies in Greenville
- Acute Myeloid Leukemia10 studies
- Sickle Cell Disease9 studies
- Idiopathic Thrombocytopenic Purpura6 studies
- Heart Failure6 studies
- Chronic Lymphocytic Leukemia5 studies
- Burkitt Lymphoma5 studies
- Obesity5 studies
- Blood Disorders5 studies
- Cancer (all types)4 studies
- Autoimmune Diseases4 studies
- Myeloproliferative Neoplasms4 studies
- Myelodysplastic Syndromes4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.